Paragon Capital Management (Colorado)’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,475
| Closed | -$30K | – | 289 |
|
|
2021
Q4 | $30K | Buy |
+2,475
| New | +$30K | ﹤0.01% | 395 |
|
|
2019
Q1 | – | Sell |
-2,475
| Closed | -$47K | – | 184 |
|
|
2018
Q4 | $47K | Hold |
2,475
| – | – | 0.02% | 187 |
|
|
2018
Q3 | $88K | Hold |
2,475
| – | – | 0.08% | 202 |
|
|
2018
Q2 | $51K | Buy |
2,475
+200
| +9% | +$4.12K | 0.05% | 196 |
|
|
2018
Q1 | $28K | Hold |
2,275
| – | – | 0.01% | 212 |
|
|
2017
Q4 | $25K | Hold |
2,275
| – | – | 0.01% | 185 |
|
|
2017
Q3 | $27K | Hold |
2,275
| – | – | 0.01% | 207 |
|
|
2017
Q2 | $39K | Hold |
2,275
| – | – | 0.02% | 170 |
|
|
2017
Q1 | $39K | Buy |
+2,275
| New | +$39K | 0.02% | 144 |
|